KemPharm stock: buy or sell?
January 17th, 2020
KemPharm, Inc., a clinical-stage specialty pharmaceutical company, discovers and develops new proprietary prodrugs in the United States.
Should I buy KemPharm stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, KemPharm stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is KemPharm stock a buy?
Banks and financial institutions post stock ratings everyday.At Stocks2.com, we collected 4 ratings published for KMPH stock in the last month. The general sentiment of these ratings is bullish for KMPH stock, with 3 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
KemPharm stock analysis
After sliding a frightening -20.00% on Jan/16, KemPharm closed yesterday at $0.42 and rocketed an extraordinary 5.00%.
After sliding for 4 days, Friday KemPharm rocketed an extraordinary 5.00%, closing at $0.42.
After boosting a super good 45.33% in a week last week, KemPharm closed this week at $0.42 and plunged a dreadful -44.00%.
KemPharm stock price history
KemPharm IPO was on April 16th, 2015 at $11.75 per share1. Since then, KMPH stock lost a -96.40%, with a yearly average of -24.10%.
1: Adjusted price after possible price splits or reverse-splits.
KemPharm stock historical price chart
KMPH stock reached 52-week highs at $2.85, and all-time highs 2015-08-14 with a price of 26.15.
KemPharm stock price target is $2.50Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We detected 4 price forecasts for KMPH stock posted in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
Financials and fundamental analysis
Earnings date and Earnings per ShareKemPharm failed experts on February when it published an Earnings per Share (EPS) of $-0.20 when the market consensus was $-0.48.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn , KemPharm annual revenues to M dollars from marked in . , its income margin (compared to sales) to , that is million.
Quarterly financial resultsReported quarter earnings marked $-5.18 million with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, KemPharm sales marked a neutral movement and stayed stable a nan%. Looking back to recent quarterly results, KemPharm posted 7 negative quarters in a row.
KemPharm ownershipWhen you are planning to buy a stock, it's always worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For KemPharm, 12.29% of all outstanding shares are owned by its staff.
In case of KemPharm stock, 23.99% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for KMPH stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related companies:
|Market cap||$15.3 M|
|Total shares||36.3 M|
|Float shares||24.5 M|
|- Institutional holdings (%)||24.0%|
|- Insider holdings (%)||12.3%|
|Shares in short selling||0.0%|
|Friday, January 17th, 2020|
|Day range||$0.40 - $0.44|
|Average true range||$0.11|
|50d mov avg||$0.45|
|100d mov avg||$0.58|
|200d mov avg||$1.02|
KemPharm performanceTo measure stock performance is always good to compare with competitors or related stocks. In the following table, we compare KemPharm performance to :